MedPath

Airway Management and Weight in Children

Not Applicable
Withdrawn
Conditions
Perioperative Respiratory Adverse Events
Airway Management
Interventions
Device: Endotracheal intubation
Device: Laryngeal mask airway
Registration Number
NCT03996343
Lead Sponsor
University of Michigan
Brief Summary

The investigators in this study want to see how overweight/obese children who undergo elective surgery requiring airway management react to general anesthesia. They believe that the incidence of perioperative respiratory adverse events (PRAE) associated with Laryngeal mask airway (LMA) use during general anesthesia in overweight/obese children is lower than that associated with endotracheal intubation (ETT).

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • sex-specific body mass index (BMI) is ≥85th percentile
  • elective surgical outpatient peripheral or lower abdominal procedures
  • Surgery length estimated to last between 30 and 120 minutes
Read More
Exclusion Criteria
  • Active gastro-esophageal reflux, possible difficult intubation or planned asleep fiber optic intubation, cardiac disease, thoracic deformities, upper abdominal, and thoracic or airway surgeries.
  • Children with active asthmatic attack or those considered to be "full stomach" will also be excluded.
  • Laparoscopic surgical procedures and those requiring extreme head-down tilt will also be excluded.
  • Children with a physiology or other condition requiring a certain type of airway for the procedure will also be excluded
  • Children whose anesthesiologist is not agreeable to randomization of airway management choice will also be excluded.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Endotracheal intubationEndotracheal intubation-
Laryngeal mask airwayLaryngeal mask airway-
Primary Outcome Measures
NameTimeMethod
Severe respiratory adverse eventsperioperative period

laryngospasm, bronchospasm

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath